Olink
Uppsala
About Olink
Olink Holding AB is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $100K – $500K
- Total funding: $117.0M
- Funding stage: M&A
- Last round: Private Equity (Jan 2023)
- Ticker: nasdaq:OLK
- Website: olink.com
- Phone: +46 (0)18 - 444 39 70
Industries & Categories
Biopharma, Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/olink-83955 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.